A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

Clinical trial NCT00577304 · UNKNOWN

Trial details

NCT number: NCT00577304
Sponsor: MediQuest Therapeutics
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Raynaud's Disease Raynaud's Disease Secondary to Scleroderma Raynaud's Disease Secondary to Other Autoimmune Disease

Start date: 2007-12-01
Primary completion: 2008-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.